VERFAHREN UND VERBINDUNGEN ZUR BEHANDLUNG PROLIFERATIVER ERKRANKUNGEN

The compounds disclosed herein are indolocarbazoles of Formula (I), which are potent CDK4 inhibitors, and are useful in the treatment of cell proliferative disorders, including cancer. Formula (I).

Saved in:
Bibliographic Details
Main Authors MALHOTRA, SUSHANT, ZHANG, FAMING, FURNESS, WAYNE, SANCHEZ-MARTINEZ, CONCEPCION, ZHU, GUOXIN, BRIGGS, LYLE, CLAWSON, KEYES, ENGLER, ALBERT, BROOKS, BURNS
Format Patent
LanguageGerman
Published 11.11.2004
Edition7
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The compounds disclosed herein are indolocarbazoles of Formula (I), which are potent CDK4 inhibitors, and are useful in the treatment of cell proliferative disorders, including cancer. Formula (I).
Bibliography:Application Number: DE20016003171T